(Q34071900)

30 July 2017

1 reference

title

Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia (English)

1 reference

ORCID Public Data File 2021

30 July 2017

1 reference

author name string

Baracos VE

series ordinal

1

1 reference

30 July 2017

publication date

1 October 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

16

1 reference

30 July 2017

issue

10

1 reference

30 July 2017

page(s)

1015-1018

1 reference

Effects of systemic inhibition of prostaglandin production on protein metabolism in tumor-bearing rats

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Induction of muscle protein degradation by a tumour factor

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Negative impact of cancer chemotherapy on protein metabolism in healthy and tumor-bearing rats

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Nutrition support in clinical practice: review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and A

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Metabolic sequelae of cancers (excluding bone marrow transplantation).

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Cancer cachexia: pathophysiological mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

The role of cytokines in cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Systemic administration of ciliary neurotrophic factor induces cachexia in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Characterization of a cancer cachectic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Metabolic abnormalities in cachexia and anorexia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Cytokines and endotoxin induce cytokine receptors in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Tumor growth and food intake in interleukin-6 gene knock-out mice

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Interleukin-1 receptor antagonist (IL-1ra) is unable to reverse cachexia in rats bearing an ascites hepatoma (Yoshida AH-130)

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Manipulation of the ubiquitin-proteasome pathway in cachexia: pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumor-bearing rats

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Anti-interleukin-6 receptor antibody prevents muscle atrophy in colon-26 adenocarcinoma-bearing mice with modulation of lysosomal and ATP-ubiquitin-dependent proteolytic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Growth hormone, insulin, and somatostatin therapy of cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Effects of nandrolone propionate on experimental tumor growth and cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Comparative effects of beta2-adrenergic agonists on muscle waste associated with tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Pharmacological interference with tissue hypercatabolism in tumour-bearing rats

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Insulin sensitivity, hormonal levels and skeletal muscle protein metabolism in tumour-bearing exercising rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

A new model of cancer cachexia: contribution of the ubiquitin-proteasome pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

Increased mRNA levels for components of the lysosomal, Ca2+-activated, and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900407-X

7 January 2021

10.1016/S0899-9007(00)00407-X

Identifiers

DOI

1 reference

30 July 2017

1 reference